Pharmaceuticals · Pharmaceuticals: Major · NSE: VIYASH · data 2026-10-30

Viyash Scientific Limited

₹218.39-2.74% on 30 OctHealth: Average 6.2/10

Feb 2026Low ₹179.89 · High ₹294.15+8.3%

In plain words

Price: 26.7% below its 52-week high of ₹298.

Delivery: 47.2% of traded shares were kept for delivery over the last 10 sessions, against 51.8% over the last 60.

A description of the data, not a recommendation.

Open full analysis — chart, results, balance sheet, red flags →

Key figures

Price

₹218.39

Market cap

₹9,924 cr

P/E

53.4

P/B

—

ROE

9.8%

ROCE

12.4%

Debt / equity

0.17

Dividend yield

0.00%

1-year return

2.0%

52-week high

₹298

52-week low

₹178.13

Operating margin

12.9%

Growth

Revenue (last 12 months)	₹3,149 cr
Net profit (last 12 months)	₹171 cr
Sales growth, 3 years (yearly)	34.1%
Profit growth, 3 years (yearly)	—

Smart-money activity

5/100 · Weak over the last ~60 sessions, data 2026-10-30

Delivery vs usual 0/30: Delivery 48.5% over the last 20 sessions vs 49.3% in the 40 before (0.98x); shares delivered per day 0.38x usual; 0 delivery-spike days (3x usual shares delivered, 40%+ delivery) in the last 20 sessions.
Bulk/block deals 0/20: No bulk or block deals in the last 90 days.
Insider / SAST buys 0/15: No insider buy or SAST acquisition filings in the last 90 days. Insider sells are not collected by the site, so only buy filings count.
Mutual fund holding 0/15: No mutual fund scheme lists this stock. Latest monthly portfolios only (top 60 holdings per scheme); month-on-month change is not stored.
Accumulation evidence 0/15: No accumulation evidence row (only saved-scan stocks have one; 0 points).
Promoter pledges 5/5: No promoter pledge filings in 90 days.

A description of recorded activity (delivery, deals, insider buys, fund holding, pledges), not a recommendation. Today's most active stocks.

Common questions

Is Viyash Scientific Limited debt-free?

Its latest reported debt-to-equity ratio is 0.17.

What is Viyash Scientific Limited's P/E ratio?

About 53.4, based on the last 12 months' earnings and a price of ₹218.39 (data 2026-10-30).

What is the 52-week high and low of Viyash Scientific Limited?

The 52-week high is ₹298 and the 52-week low is ₹178.13.

Similar companies

Strides Pharma Science Ltd (STAR) · Blue Jet Healthcare Limited (BLUEJET) · Procter & Gamble Health Ltd. (PGHL) · Aarti Pharmalabs Limited (AARTIPHARM) · Symbiotec Pharmalab Limited (SYMBIOTEC)

The full analysis has the price chart, every quarterly result with YoY/QoQ growth, the balance sheet and cash flow with an accounting red-flag check, shareholding quarter by quarter with big investors, news, filings and bulk/block deals.

Open VIYASH in NSE Scanner →